Back to Search
Start Over
Nivolumab/pembrolizumab/sintilimab: No therapeutic response, off-label use and immune-related pancreatitis: 5 case reports.
- Source :
-
Reactions Weekly . Jun2023, Vol. 1960 Issue 1, p359-359. 1p. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 01149954
- Volume :
- 1960
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Reactions Weekly
- Publication Type :
- Periodical
- Accession number :
- 164226078
- Full Text :
- https://doi.org/10.1007/s40278-023-41187-9